Questions: Fungal Cell Wall Composition and Biosynthesis

Question 1

A researcher tests a new compound that inhibits β-1,3-glucan synthase. Which cells would be most affected?

• A. Human epithelial cells, because mammalian cells also produce β-glucans for structural support
• B. Bacterial cells, because bacterial peptidoglycan and fungal β-glucans share structural similarities
• C. Fungal cells, because β-1,3-glucan is a key structural matrix component of the fungal cell wall absent in host cells
• D. Plant cells, because plant cellulose and fungal β-glucans use the same biosynthetic enzyme

Answer: (C)

β-1,3-glucans are specific to the fungal cell wall. Animal cells have no cell wall at all, so β-1,3-glucan synthase inhibitors (echinocandins like caspofungin) have no target in human cells — the basis of their selective toxicity. Bacterial cells have peptidoglycan walls, not glucan walls. Plant cells have cellulose (β-1,4-linked glucose), synthesized by a distinct enzyme (cellulose synthase).

Question 2

The monomer of chitin is N-acetylglucosamine (GlcNAc) linked by β-1,4 bonds — the same monomer found in bacterial peptidoglycan. What distinguishes fungal chitin from bacterial peptidoglycan structurally?

• A. Chitin uses α-1,4 bonds while peptidoglycan uses β-1,4 bonds, giving them different properties
• B. Peptidoglycan is a pure GlcNAc homopolymer; chitin alternates GlcNAc with N-acetylmuramic acid
• C. Chitin is a pure GlcNAc homopolymer; peptidoglycan alternates GlcNAc with N-acetylmuramic acid and cross-links chains with peptide bridges
• D. They are structurally identical; the distinction is only in their cellular location

Answer: (C)

Bacterial peptidoglycan alternates GlcNAc with N-acetylmuramic acid (MurNAc) and cross-links adjacent glycan chains through short peptide bridges — this peptide cross-linking is the target of penicillin. Fungal chitin is a pure homopolymer of GlcNAc with β-1,4 bonds and no peptide component. The shared monomer is convergent; the polymer architectures are distinct, which is why β-lactam antibiotics have no effect on fungi.

Question 3

The outermost layer of the fungal cell wall, which includes mannoproteins, is the component most directly recognized by the human innate immune system.

• T. True
• F. False

Answer: True

Mannoproteins project from the fungal cell surface and are detected by mannose receptors on macrophages and dendritic cells — a key pattern recognition event in antifungal innate immunity. β-1,3-glucans (recognized by Dectin-1) are also important triggers, somewhat shielded by the outer mannoprotein layer in some growth conditions. The outermost surface structures are the primary contact point with host immune cells.

Question 4

Because chitin and cellulose are both structural polysaccharides made of glucose-derived monomers linked by β-glycosidic bonds, antifungals targeting chitin synthesis would also damage plant cells.

• T. True
• F. False

Answer: False

While both chitin and cellulose are β-linked polysaccharides, they use different monomers (N-acetylglucosamine vs. glucose) and different enzymes (chitin synthase vs. cellulose synthase). Compounds that inhibit chitin synthase (like nikkomycin) are selective for chitin-containing organisms and have no effect on cellulose synthesis. Selective toxicity between kingdoms often exploits exactly these molecular differences — same structural role, different biochemical implementation.

Question 5

Why is the fungal cell wall — rather than a fungal membrane component — the preferred target for antifungal drugs, and what property makes this targeting selective?

Model answer: The fungal cell wall is an ideal drug target because it is structurally essential for the fungus (maintaining osmotic integrity) yet entirely absent in animal cells. Human cells have plasma membranes but no cell walls, so drugs targeting cell wall biosynthesis (β-glucan synthesis or chitin synthesis) have no equivalent target in the host. This structural asymmetry allows selective toxicity: the drug destroys the fungus without affecting the patient's cells. By contrast, targeting fungal membranes is more problematic because both fungi and humans have sterols — azoles and polyenes exploit the difference between fungal ergosterol and human cholesterol, but the selectivity window is narrower.

This is the same logic that makes β-lactam antibiotics useful against bacteria — targeting the peptidoglycan wall that bacteria have and human cells lack. The layered architecture of the fungal wall (chitin → β-glucan → mannoprotein) provides multiple potential targets, of which β-1,3-glucan synthase (inhibited by echinocandins) has proven most clinically successful.